• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 与眼睛:对传播、检测和眼部表现相关文献的综述。

SARS-CoV-2 and the Eyes: A Review of the Literature on Transmission, Detection, and Ocular Manifestations.

机构信息

Department of Ophthalmology, Medical University of Warsaw, Warsaw, Poland.

出版信息

Med Sci Monit. 2021 Sep 11;27:e931863. doi: 10.12659/MSM.931863.

DOI:10.12659/MSM.931863
PMID:34508064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8439119/
Abstract

During the coronavirus disease 2019 (COVID-19) pandemic, numerous reports of ocular anomalies occurring in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged. The most frequently reported pathology is conjunctivitis, which may be the first or only clinical manifestation of the disease. Involvement of SARS-CoV-2 in development of alterations in other ocular structures was suggested, including the cornea, the retina, and blood vessels. Possible mechanisms include direct activity of the viral agent, as well as systemic inflammatory response with accompanying thromboembolic complications. Genetic material of SARS-CoV-2 was detected in ocular secretions of infected individuals, including asymptomatic patients. Moreover, angiotensin-converting enzyme 2 (ACE2), a receptor protein used by the virus to enter the cell, has been found on the surface of various structures of the eye, which indicates a risk of transmission through ocular tissues. Therefore, it is crucial to use eye protection by medical professionals having contact with potentially infected patients. This paper is a review of the literature regarding ocular manifestations of SARS-CoV-2 infection and a summary of the current state of knowledge about possibility of transmission from an ophthalmology point of view. For data collection, a thorough PubMed search was performed, using the key words: "COVID ocular", "COVID eye", "SARS-CoV-2 ocular", and "SARS-CoV-2 eye". Conclusions: SARS-CoV-2 infection may manifest itself in various ocular conditions. Eye protection should not be neglected, as recent studies suggest the eye as a potential route of transmission. Further search for adequate safety measures in ophthalmology practice is required.

摘要

在 2019 冠状病毒病(COVID-19)大流行期间,有大量报告称严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染患者出现眼部异常。最常报告的病理学改变是结膜炎,它可能是该病的首发或唯一临床表现。SARS-CoV-2 可能参与了其他眼部结构改变的发生,包括角膜、视网膜和血管。可能的发病机制包括病毒因子的直接作用,以及伴有血栓栓塞并发症的全身炎症反应。在感染个体的眼部分泌物中,包括无症状患者,均检测到 SARS-CoV-2 的遗传物质。此外,病毒用来进入细胞的受体蛋白血管紧张素转换酶 2(ACE2)已在眼部各种结构的表面被发现,这表明通过眼部组织传播的风险。因此,接触可能感染患者的医务人员使用眼部防护至关重要。本文综述了 SARS-CoV-2 感染的眼部表现的文献,并从眼科角度总结了目前关于传播可能性的知识现状。为了收集数据,我们在 PubMed 上进行了彻底的搜索,使用的关键词是:“COVID 眼”、“COVID 眼部”、“SARS-CoV-2 眼”和“SARS-CoV-2 眼部”。结论:SARS-CoV-2 感染可能表现为各种眼部疾病。不应忽视眼部防护,因为最近的研究表明眼部是潜在的传播途径。需要进一步寻找在眼科实践中使用的适当安全措施。

相似文献

1
SARS-CoV-2 and the Eyes: A Review of the Literature on Transmission, Detection, and Ocular Manifestations.SARS-CoV-2 与眼睛:对传播、检测和眼部表现相关文献的综述。
Med Sci Monit. 2021 Sep 11;27:e931863. doi: 10.12659/MSM.931863.
2
COVID-19 and the Eye: Ocular Manifestations, Treatment and Protection Measures.新型冠状病毒肺炎与眼睛:眼部表现、治疗和防护措施。
Ocul Immunol Inflamm. 2021 Aug 18;29(6):1225-1233. doi: 10.1080/09273948.2021.1977829. Epub 2021 Oct 14.
3
Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review.新型冠状病毒病 2019(SARS-CoV-2)与眼部组织和分泌物定植:系统评价。
Eye (Lond). 2020 Jul;34(7):1206-1211. doi: 10.1038/s41433-020-0926-9. Epub 2020 May 18.
4
The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies.SARS-CoV-2 感染在眼表面的传播及预防策略。
Cells. 2021 Apr 2;10(4):796. doi: 10.3390/cells10040796.
5
SARS-COV-2 in Ophthalmology: Current Evidence and Standards for Clinical Practice.眼科领域的新型冠状病毒肺炎:临床实践的当前证据与标准
Acta Med Port. 2020 Sep 1;33(9):593-600. doi: 10.20344/amp.14118. Epub 2020 Jun 16.
6
The implication of ocular manifestation of COVID-19 for medical staff and patients - systematic review.新型冠状病毒肺炎眼部表现对医护人员和患者的影响——系统评价
Ann Agric Environ Med. 2020 Jun 19;27(2):165-170. doi: 10.26444/aaem/122790. Epub 2020 Jun 5.
7
[Ocular symptoms in SARS-CoV-2 infection].[严重急性呼吸综合征冠状病毒2型感染中的眼部症状]
Pol Merkur Lekarski. 2022 Apr 19;50(296):86-93.
8
COVID-19-related Conjunctivitis Review: Clinical Features and Management.COVID-19 相关结膜炎综述:临床特征与管理。
Ocul Immunol Inflamm. 2023 May;31(4):778-784. doi: 10.1080/09273948.2022.2054432. Epub 2022 Apr 8.
9
Ocular Pathology and Occasionally Detectable Intraocular Severe Acute Respiratory Syndrome Coronavirus-2 RNA in Five Fatal Coronavirus Disease-19 Cases.五例新冠肺炎死亡病例的眼部病理及偶尔可检测到的眼内严重急性呼吸综合征冠状病毒 2 型 RNA。
Ophthalmic Res. 2021;64(5):785-792. doi: 10.1159/000514573. Epub 2021 Jan 20.
10
In the eye of the storm: SARS-CoV-2 infection and replication at the ocular surface?风暴眼中:SARS-CoV-2 在眼表的感染和复制?
Stem Cells Transl Med. 2021 Jul;10(7):976-986. doi: 10.1002/sctm.20-0543. Epub 2021 Mar 12.

引用本文的文献

1
COVID-19 - multisystem disease.新冠病毒病——多系统疾病。
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):61-67. doi: 10.47162/RJME.66.1.05.
2
Conditional reprogrammed human limbal epithelial cell model for anti-SARS-CoV-2 drug screening.用于抗SARS-CoV-2药物筛选的条件重编程人角膜缘上皮细胞模型
Heliyon. 2024 Apr 23;10(9):e30044. doi: 10.1016/j.heliyon.2024.e30044. eCollection 2024 May 15.
3
Dry eye symptoms are prevalent in moderate-severe COVID-19, while SARS-COV-2 presence is higher in mild COVID-19: Possible ocular transmission risk of COVID-19.干眼症症状在中重度新冠肺炎患者中普遍存在,而轻度新冠肺炎患者中新型冠状病毒的存在率更高:新冠肺炎可能存在眼部传播风险。
Heliyon. 2024 Mar 27;10(7):e28649. doi: 10.1016/j.heliyon.2024.e28649. eCollection 2024 Apr 15.
4
COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.COVID-19 和阿尔茨海默病具有共同的神经和眼科表现:后疫情时代的双向风险。
Cells. 2023 Nov 10;12(22):2601. doi: 10.3390/cells12222601.
5
Virtual reality for assessing stereopsis performance and eye characteristics in Post-COVID.虚拟现实评估新冠病毒感染后立体视功能和眼特征
Sci Rep. 2023 Aug 13;13(1):13167. doi: 10.1038/s41598-023-40263-w.
6
Long-term effects of SARS-CoV-2 infection on human brain and memory.新型冠状病毒2(SARS-CoV-2)感染对人类大脑和记忆的长期影响。
Cell Death Discov. 2023 Jun 29;9(1):196. doi: 10.1038/s41420-023-01512-z.
7
Incidence and clinical characteristic of ocular surface manifestation: an evaluation of conjunctival swab results in Corona Virus 2019 (COVID-19) patients in Jakarta, Indonesia.眼表表现的发病率及临床特征:对印度尼西亚雅加达2019冠状病毒病(COVID-19)患者结膜拭子结果的评估
J Ophthalmic Inflamm Infect. 2023 Apr 25;13(1):20. doi: 10.1186/s12348-023-00343-4.
8
Ocular Symptoms Associated with COVID-19 Are Correlated with the Expression Profile of Mouse SARS-CoV-2 Binding Sites.与 COVID-19 相关的眼部症状与小鼠 SARS-CoV-2 结合位点的表达谱相关。
Viruses. 2023 Jan 26;15(2):354. doi: 10.3390/v15020354.
9
Insights on the possibility of SARS-CoV-2 transmission through the eyes.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)通过眼睛传播可能性的见解。
Int J Ophthalmol. 2022 Nov 18;15(11):1857-1863. doi: 10.18240/ijo.2022.11.18. eCollection 2022.
10
Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation.MDM2抑制剂Nutlin-3通过激活p53抵抗SARS-CoV-2眼部感染的治疗潜力。
Front Med (Lausanne). 2022 Jul 14;9:902713. doi: 10.3389/fmed.2022.902713. eCollection 2022.

本文引用的文献

1
Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective.新型冠状病毒肺炎患者的神经后遗症:病理组织学观察。
Int J Environ Res Public Health. 2021 Feb 3;18(4):1415. doi: 10.3390/ijerph18041415.
2
Anterior Acute Uveitis Report in a SARS-CoV-2 Patient Managed with Adjunctive Topical Antiseptic Prophylaxis Preventing 2019-nCoV Spread Through the Ocular Surface Route.一名接受辅助局部抗菌预防以防止2019-nCoV通过眼表途径传播的SARS-CoV-2患者的前急性葡萄膜炎报告
Int Med Case Rep J. 2020 Oct 13;13:513-520. doi: 10.2147/IMCRJ.S260252. eCollection 2020.
3
Bilateral Central Retinal Vein Occlusion in a 40-Year-Old Man with Severe Coronavirus Disease 2019 (COVID-19) Pneumonia.一名患有重症2019冠状病毒病(COVID-19)肺炎的40岁男性双侧视网膜中央静脉阻塞
Am J Case Rep. 2020 Oct 29;21:e927691. doi: 10.12659/AJCR.927691.
4
Retinal involvement and ocular findings in COVID-19 pneumonia patients.COVID-19 肺炎患者的视网膜病变及眼部表现。
Sci Rep. 2020 Oct 15;10(1):17419. doi: 10.1038/s41598-020-74446-6.
5
Ocular Surface and Conjunctival Cytology Findings in Patients With Confirmed COVID-19.确诊 COVID-19 患者的眼表面和结膜细胞学发现。
Eye Contact Lens. 2021 Apr 1;47(4):168-173. doi: 10.1097/ICL.0000000000000752.
6
Third Cranial Nerve Palsy Presenting with Unilateral Diplopia and Strabismus in a 24-Year-Old Woman with COVID-19.一名24岁感染新冠病毒的女性出现单侧复视和斜视,伴第三颅神经麻痹
Am J Case Rep. 2020 Oct 15;21:e925897. doi: 10.12659/AJCR.925897.
7
New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review.COVID-19 患者新发眼肌型重症肌无力:一例新病例报告及文献复习。
J Neurol. 2021 Aug;268(8):2690-2696. doi: 10.1007/s00415-020-10263-1. Epub 2020 Oct 12.
8
Ophthalmic and Neuro-ophthalmic Manifestations of Coronavirus Disease 2019 (COVID-19).新型冠状病毒肺炎(COVID-19)的眼科和神经眼科表现。
Ocul Immunol Inflamm. 2020 Nov 16;28(8):1285-1289. doi: 10.1080/09273948.2020.1817497. Epub 2020 Oct 6.
9
Retinal findings in patients with COVID-19: Results from the SERPICO-19 study.新型冠状病毒肺炎患者的视网膜表现:SERPICO-19研究结果
EClinicalMedicine. 2020 Oct;27:100550. doi: 10.1016/j.eclinm.2020.100550. Epub 2020 Sep 20.
10
Retinal vein occlusion in COVID-19: A novel entity.新冠病毒相关的视网膜静脉阻塞:一种新的病症。
Indian J Ophthalmol. 2020 Oct;68(10):2291-2293. doi: 10.4103/ijo.IJO_2380_20.